Concentra Group (CON) Margin Compression Challenges Bullish Earnings Growth Narrative

Concentra Group Holdings Parent FY 2025 earnings snapshot

Concentra Group Holdings Parent (CON) has wrapped up FY 2025 with Q4 revenue of US$539.1 million and basic EPS of US$0.28, capping off a year where trailing 12 month revenue reached about US$2.2 billion and EPS sat at US$1.30. The company has seen quarterly revenue move from US$465.0 million in Q4 2024 to US$539.1 million in Q4 2025, while basic EPS over that same Q4 stretch shifted from US$0.17 to US$0.28, setting up a situation where investors are watching how a 7.7% trailing net profit margin, down from 8.8% last year, frames the balance between growth and margin pressure.

See our full analysis for Concentra Group Holdings Parent.

With the headline numbers on the table, the next step is to see how these results line up with the key stories investors follow about Concentra Group Holdings Parent, and how the latest margin and growth trends might lead those narratives to adjust.

See what the community is saying about Concentra Group Holdings Parent

LTM revenue passes US$2.1b while margins ease

• Over the last twelve months, Concentra generated about US$2.2b in revenue with net income of US$166.4 million, which works out to a 7.7% net margin compared with 8.8% a year earlier.
• Analysts' consensus view links this margin picture to a mixed story, where:
  • Forecast revenue growth of about 6.2% a year and earnings growth of about 11.6% a year sit alongside that 7.7% net margin, which is lower than last year and suggests profitability is not moving in lockstep with the top line.
  • Past five year earnings declined about 6.1% a year, while the most recent year grew 0.05%, so the data supports a more gradual earnings recovery than the faster growth path some bulls might hope for.

Quarterly EPS trends versus long term growth story

• Across FY 2025, basic EPS moved between US$0.30 in Q1 and US$0.38 in Q3, ending at about US$0.28 in Q4, while trailing twelve month EPS sits at US$1.30.
• Bulls point to growth drivers in occupational health and clinic expansion, and the numbers give a mixed check on that view:
  • Q4 2025 revenue of US$539.1 million is higher than the US$465.0 million reported in Q4 2024 and sits within a trailing twelve month revenue base of roughly US$2.2b, which lines up with the idea that scale and service expansion are feeding into higher volumes.
  • At the same time, the drop in trailing margin from 8.8% to 7.7% means that even as analysts forecast earnings to grow about 11.6% a year, the current profitability trend is more muted than a straightforward growth story might suggest.

Over the last year, bulls have focused on rising clinic scale and occupational health demand, but these EPS and margin trends show why many also keep a close eye on how efficiently that growth turns into profits. 🐂 Concentra Group Holdings Parent Bull Case

P/E discount and debt coverage risk

• Concentra trades on a trailing P/E of 18.5x at a share price of US$24.05, below the US Healthcare industry average of 23.8x and peer average of 24.7x, and around 3.7% below an estimated DCF fair value of US$24.98, while debt is flagged as not well covered by operating cash flow.
• Bears focus on that balance sheet flag, and the current data gives them clear talking points:
  • The combination of a 7.7% trailing net margin and debt that is not well covered by operating cash flow means a sizable part of the risk case is tied to cash generation rather than just accounting earnings.
  • Even with the shares trading below the DCF fair value of US$24.98 and below industry and peer P/E multiples, the weak debt coverage is a concrete issue that can justify caution for investors who prioritize balance sheet strength.

If you are weighing that lower 18.5x P/E against the debt coverage concern, it helps to see how cautious investors frame the downside case in detail. 🐻 Concentra Group Holdings Parent Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Concentra Group Holdings Parent on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strengths and pressure points leaves you with questions, take a moment now to review the details yourself and weigh up the trade offs, then check out 3 key rewards and 1 important warning sign to see how the key risks and potential rewards stack up side by side.

See What Else Is Out There

Concentra's softer 7.7% net margin, weak debt coverage by operating cash flow and trailing EPS pattern leave clear questions about balance sheet resilience.

If balance sheet and cash flow risks here make you uneasy, take a few minutes to check companies in our solid balance sheet and fundamentals stocks screener (39 results) that aim to prioritize financial strength and stability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com